UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
U-Haul Holding Co
UHAL
$14.7B
| $1.47M | ﹤0.01% |
45,000
+1,000
| +2% | +$32.7K |
|
1477
Groupon
GRPN
$977M
| $1.47M | ﹤0.01% |
14,615
+940
| +7% | +$121K |
|
|
CVG
1478
DELISTED
Convergys
CVG
| $1.47M | ﹤0.01% |
57,696
+3,500
| +6% | +$84.7K |
|
1479
EPAM Systems
EPAM
$5.08B
| $1.47M | ﹤0.01% |
20,600
+3,200
| +18% | +$219K |
|
1480
John Wiley & Sons Class A
WLY
$2.74B
| $1.46M | ﹤0.01% |
26,825
+2,300
| +9% | +$134K |
|
1481
ACI Worldwide
ACIW
$5.63B
| $1.45M | ﹤0.01% |
58,997
+6,200
| +12% | +$146K |
|
|
INFN
1482
DELISTED
Infinera Corporation Common Stock
INFN
| $1.45M | ﹤0.01% |
69,078
+5,500
| +9% | +$112K |
|
1483
Valley National Bancorp
VLY
$8.11B
| $1.45M | ﹤0.01% |
140,433
+17,300
| +14% | +$169K |
|
|
BID
1484
DELISTED
Sotheby's
BID
| $1.45M | ﹤0.01% |
31,998
+3,900
| +14% | +$173K |
|
1485
Cracker Barrel
CBRL
$1.29B
| $1.45M | ﹤0.01% |
9,699
-300
| -3% | -$42.7K |
|
|
KLXI
1486
DELISTED
KLX Inc.
KLXI
| $1.45M | ﹤0.01% |
38,865
-1,326
| -3% | -$47.9K |
|
|
ECHO
1487
EchoStar
ECHO
$25.5B
| $1.44M | ﹤0.01% |
36,558
+2,505
| +7% | +$103K |
|
1488
Equinor
EQNR
$93.1B
| $1.44M | ﹤0.01% |
80,261
+10,196
| +15% | +$197K |
|
|
UNT
1489
DELISTED
UNIT Corporation
UNT
| $1.43M | ﹤0.01% |
52,872
+2,176
| +4% | +$68.6K |
|
1490
Avista
AVA
$3.24B
| $1.43M | ﹤0.01% |
46,723
+4,400
| +10% | +$142K |
|
1491
Viasat
VSAT
$11.7B
| $1.43M | ﹤0.01% |
23,681
+1,782
| +8% | +$111K |
|
1492
Euronet Worldwide
EEFT
$2.79B
| $1.43M | ﹤0.01% |
23,098
+2,000
| +9% | +$119K |
|
|
BRFS
1493
DELISTED
BRF SA
BRFS
| $1.42M | ﹤0.01% |
68,100
-21,171
| -24% | -$447K |
|
|
SYA
1494
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $1.42M | ﹤0.01% |
58,597
+4,800
| +9% | +$117K |
|
|
AVNS
1495
DELISTED
Avanos Medical
AVNS
| $1.41M | ﹤0.01% |
34,711
+558
| +2% | +$25K |
|
|
ANN
1496
DELISTED
ANN INC
ANN
| $1.4M | ﹤0.01% |
29,042
-147,600
| -84% | -$6.38M |
|
|
CNW
1497
DELISTED
CON-WAY INC.
CNW
| $1.4M | ﹤0.01% |
36,498
-115
| -0.3% | -$4.78K |
|
|
ROSE
1498
DELISTED
ROSETTA RESOURCES INC
ROSE
| $1.4M | ﹤0.01% |
60,562
+20,468
| +51% | +$467K |
|
|
MRC
1499
DELISTED
MRC Global
MRC
| $1.4M | ﹤0.01% |
90,563
+6,600
| +8% | +$99.6K |
|
1500
Take-Two Interactive
TTWO
$43.9B
| $1.4M | ﹤0.01% |
50,697
+7,900
| +18% | +$208K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.